Breaking News Instant updates and real-time market news.

EVER

EverQuote

$7.84

-0.06 (-0.76%)

04:55
03/25/19
03/25
04:55
03/25/19
04:55

EverQuote management to meet with Oppenheimer

Meeting to be held in New York on March 25 hosted by Oppenheimer.

  • 25

    Mar

  • 28

    Mar

EVER EverQuote
$7.84

-0.06 (-0.76%)

02/26/19
ADAM
02/26/19
NO CHANGE
Target $12
ADAM
Buy
EverQuote Q4 results showed trends stabilizing, says Canaccord
Canaccord analyst Michael Graham said the Q4 results for EverQuote showed encouraging signs of stabilization. He noted revenue growth was driven by a balance of volume and revenue per quote request. He is now looking ahead to positive milestones, including the launch of renters and commercial verticals and the roll-out of EverDrive to over 20 more states. Graham reiterated his Buy rating and lowered his price target to $12 from $14 on EverQuote shares.
02/26/19
OPCO
02/26/19
NO CHANGE
Target $11
OPCO
Outperform
EverQuote price target lowered to $11 from $16 at Oppenheimer
Oppenheimer analyst Jed Kelly lowered his price target for EverQuote to $11 from $16 following quarterly results, which suggest Q4 traffic headwinds were company specific. The analyst reiterates an Outperform rating on the shares as he is more encouraged toward the company's long-term outlook after it guided 2019 revenue above the Street on more balanced growth between pricing and volume, that implies Q4 marketing initiatives are re-accelerating profitable traffic.
02/26/19
BOFA
02/26/19
UPGRADE
Target $10.5
BOFA
Buy
EverQuote upgraded to Buy following Q4 beat at BofA/Merrill
As previously reported, BofA/Merrill upgraded EverQuote to Buy from Neutral with a new $10.50 price target following the Q4 beat. Analyst Nat Schindler said user growth has re-accelerated, supporting evidence of a turnaround, and thinks estimates are conservative and views the risk/reward as attractive.
02/26/19
02/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Exact Sciences (EXAS) upgraded to Buy from Neutral at Goldman Sachs by analyst Patrick Donnelly, who said the current momentum of the Cologuard commercial ramp provides "strong basis" for the company's premium valuation while the combination of positive Cologuard catalysts and new product roll-outs provide upside to current levels, even after the stock's 75% rally since the beginning of 2018. Exact Sciences is a "must-own growth stock" given the "clean runway forward that is largely in its control with potential for discovery value in the pipeline outside of Cologuard," the analyst said. 2. Siemens (SIEGY) upgraded to Overweight from Neutral at JPMorgan by analyst Andreas Willi, who sees a relative valuation opportunity after the stock's 27% underperformance over the past two years. He believes investor sentiment can improve "after a period where the story has drifted." 3. Kadmon (KDMN) upgraded to Buy from Neutral at Citi by analyst Robyn Karnauskas, who assigned a 50% probability to KD-025 in chronic graft versus host disease with an unadjusted ~$900M market opportunity. However, upside to the stock will depend on quality of the data likely, Karnauskas said. 4. EverQuote (EVER) upgraded to Buy following Q4 beat at BofA/Merrill by analyst Mat Schindler, who said user growth has re-accelerated, supporting evidence of a turnaround, and thinks estimates are conservative and views the risk/reward as attractive. 5. Ally Financial (ALLY) upgraded to Buy from Hold at Sandler O'Neill by analyst Christopher Donat, who said he believes Ally's near-prime auto finance book is "meaningfully less risky" than Santander Consumer's (SC) book or the unsecured credit cards of Discover (DFS) and Capital One (COF), yet all four stocks trade at similar multiples. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TRVN

Trevena

$0.68

(0.00%)

07:09
11/20/19
11/20
07:09
11/20/19
07:09
Hot Stocks
Trevena announces publication of results from Phase 1 PK studies of oliceridine »

Trevena announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBIO

Mustang Bio

$2.57

-0.06 (-2.28%)

07:09
11/20/19
11/20
07:09
11/20/19
07:09
Initiation
Mustang Bio initiated  »

Mustang Bio assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COWN

Cowen Group

$15.35

0.34 (2.27%)

07:08
11/20/19
11/20
07:08
11/20/19
07:08
Conference/Events
Cowen Group management to meet with Sandler ONeill »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LDOS

Leidos

$91.73

0.35 (0.38%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Hot Stocks
Leidos teams up with Pharicode on NEST contract to provide IT services to NASA »

Pharicode teamed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CO

Global Cord Blood

$4.56

-0.01 (-0.22%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Hot Stocks
Global Cord Blood comments on new Chinese regulation »

Global Cord Blood…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.07

-0.05 (-0.11%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Recommendations
Endava analyst commentary  »

Endava price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

CI

Cigna

$200.06

1.645 (0.83%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Conference/Events
Cigna management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 09

    Dec

  • 06

    Feb

ROK

Rockwell Automation

$196.69

-0.95 (-0.48%)

, ANSS

Ansys

$242.54

3.87 (1.62%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Hot Stocks
Rockwell Automation, Ansys announce strategic partnership »

Industrial companies now…

ROK

Rockwell Automation

$196.69

-0.95 (-0.48%)

ANSS

Ansys

$242.54

3.87 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 02

    Dec

  • 11

    Dec

BCLI

BrainStorm

$3.79

0.095 (2.57%)

07:06
11/20/19
11/20
07:06
11/20/19
07:06
Hot Stocks
BrainStorm announces publication of NurOwn ALS Phase 2 clinical trial data »

BrainStorm Cell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

JNJ

Johnson & Johnson

$134.81

-0.03 (-0.02%)

07:05
11/20/19
11/20
07:05
11/20/19
07:05
Initiation
Johnson & Johnson initiated  »

Cantor Fitzgerald starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 21

    Jan

ACB

Aurora Cannabis

$2.33

0.065 (2.87%)

07:05
11/20/19
11/20
07:05
11/20/19
07:05
Hot Stocks
Aurora Cannabis names Dr. Shane Morris CPO and Andre Jerome CIO »

Aurora Cannabis is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRRA

Sierra Oncology

$0.25

0.0095 (3.99%)

07:04
11/20/19
11/20
07:04
11/20/19
07:04
Hot Stocks
Sierra Oncology launches Momentum Phase 3 clinical trial in Myelofibrosis »

Sierra Oncology has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

TDG

TransDigm

$568.99

0.67 (0.12%)

07:04
11/20/19
11/20
07:04
11/20/19
07:04
Recommendations
TransDigm analyst commentary  »

TransDigm price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAV

Aravive

$6.69

0.19 (2.92%)

07:03
11/20/19
11/20
07:03
11/20/19
07:03
Hot Stocks
Aravive reports data from ongoing Phase 1b portion of AVB-500 trial »

Aravive announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANIX

Anixa Biosciences

$3.62

-0.135 (-3.60%)

07:03
11/20/19
11/20
07:03
11/20/19
07:03
Hot Stocks
Anixa Biosciences announces collaboration with Idaho Urologic Institute »

Anixa Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$205.94

-2.24 (-1.08%)

07:03
11/20/19
11/20
07:03
11/20/19
07:03
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:02
11/20/19
11/20
07:02
11/20/19
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 11/15 MBA…

BR

Broadridge

$122.16

1.55 (1.29%)

07:02
11/20/19
11/20
07:02
11/20/19
07:02
Hot Stocks
Broadridge acquires ClearStructure Financial Technology, terms not disclosed »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$56.48

-1.14 (-1.98%)

07:00
11/20/19
11/20
07:00
11/20/19
07:00
Hot Stocks
Bristol-Myers: Statistically significant benefit not reached in CheckMate -915 »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:00
11/20/19
11/20
07:00
11/20/19
07:00
General news
European stock markets sold off, »

European stock markets…

PAGS

PagSeguro Digital

$36.81

-1.04 (-2.75%)

06:59
11/20/19
11/20
06:59
11/20/19
06:59
Recommendations
PagSeguro Digital analyst commentary  »

PagSeguro Digital price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

NWBI

Northwest Bancshares

$16.76

(0.00%)

06:58
11/20/19
11/20
06:58
11/20/19
06:58
Initiation
Northwest Bancshares initiated  »

Northwest Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALX

Calix

$7.71

0.06 (0.78%)

06:57
11/20/19
11/20
06:57
11/20/19
06:57
Conference/Events
Calix management to meet with Northland »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FTNT

Fortinet

$105.04

1.24 (1.19%)

06:56
11/20/19
11/20
06:56
11/20/19
06:56
Recommendations
Fortinet analyst commentary  »

Fortinet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

RES

RPC, Inc.

$3.84

-0.015 (-0.39%)

, NEX

NexTier Oilfield

$4.67

-0.07 (-1.48%)

06:56
11/20/19
11/20
06:56
11/20/19
06:56
Downgrade
RPC, Inc., NexTier Oilfield rating change  »

Citi downgrades RPC to…

RES

RPC, Inc.

$3.84

-0.015 (-0.39%)

NEX

NexTier Oilfield

$4.67

-0.07 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.